Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

MDCX stock hub

Medicus Pharma Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MDCXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MDCX

In the news

Latest news · MDCX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-2,981.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-357.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MDCX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

USD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001997296
Company name	Medicus Pharma Ltd.
Country	United States
Country code	US
Employees	16
Enterprise value	$10.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - General
Isin	CA58471K2020
Last refreshed	2026-05-10
Market cap	$14M
Market cap category	Nano-Cap
Price	$0.34
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	MDCX
Website	https://medicuspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-337.51%
P/B ratio	375.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-47.3M
Net Income Growth Years	0%
Profit Per Employee	$-3M
ROA	-204
ROCE	-20,793.8
ROE	-2,981.2
ROIC	-357.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-92.17%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$10.1M
Cash	$8.7M
Current Assets	$9.9M
Current Liabilities	$9.9M
Debt	$5.5M
Debt Equity	$147
Equity	$37,311
Interest Coverage	-129.9
Liabilities	$10M
Long Term Assets	$170,733
Long Term Liabilities	$86,004
Net Cash	$3.2M
Net Cash By Market Cap	$23.04
Net Cash Growth	-15.98%
Net Debt Equity	$-86.52
Tangible Book Value	$-67,554
Tangible Book Value Per Share	$-0
WACC	0.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1
Net Working Capital	$-3.4M
Quick ratio	0.88
Working Capital	$-47,418

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-79.68%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-92.15%
200-day SMA	1.6
50-day SMA	0.5
50-day SMA vs 200-day SMA	50under200
All Time High	8.94
All Time High Change	-96.25%
All Time High Date	2025-05-20
All Time Low	0.25
All Time Low Change	34%
All Time Low Date	2026-05-05
ATR	0.05
Beta	-0.91
Beta1y	2
Beta2y	1.3
Ch YTD	-78.1
High	0.36
High52	8.94
High52 Date	2025-05-20
High52ch	-96.25%
Low	0.3
Low52	0.25
Low52 Date	2026-05-05
Low52ch	34%
Ma50ch	-32.58%
Premarket Change Percent	-2.71
Premarket Price	$0.31
Premarket Volume	280,892
Price vs 200-day SMA	-79.1%
RSI	43.4
RSI Monthly	33.87
RSI Weekly	31.15
Sharpe ratio	-1.17x
Sortino ratio	-1.44
Total Return	-79.68%
Tr YTD	-78.1
Tr1m	-25.56%
Tr1w	17.42%
Tr3m	-69.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.21
Operating Income	$-25.6M
Price target	$9
Price Target Change	$2,587

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,475,211%
Float Percent	84.83%
Net Borrowing	4,475,186
Shares Insiders	8.2%
Shares Institutions	11.72%
Shares Out	41,818,092
Shares Qo Q	-0.16%
Shares Yo Y	79.68%
Short Float	3.58%
Short Ratio	0.36
Short Shares	3.03

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	8,145,277.5x
Bv Per Share	-0
Ch1m	-25.56
Ch1w	17.42
Ch1y	-92.15
Ch3m	-69.82
Ch6m	-85.98
Change	6.69%
Change From Open	8.59
Close	0.31
Days Gap	-1.75
Dollar Volume	994,346
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-25.6M
EPS	$-2.74
F Score	1
Financing CF	31,939,785
Fiscal Year End	December
Founded	2,008
Investing CF	-4,619,152
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Last Split Date	2024-10-25
Last Split Type	Reverse
Last10k Filing Date	2026-03-25
Ma150	1.37
Ma150ch	-75.55%
Ma20	0.32
Ma20ch	4.39%
Net CF	4,540,895
Next Earnings Date	2026-05-22
Open	0.31
Optionable	No
Position In Range	60
Post Close	0.34
Postmarket Change Percent	-3.67
Postmarket Price	$0.32
Ppne	170,733
Pre Close	0.31
Price Date	2026-05-08
Relative Volume	0.36x
Share Based Comp	1,512,194
Tr6m	-85.98%
Us State	Pennsylvania
Volume	2,968,197

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MDCX pay a dividend?

Capital-return profile for this ticker.

Performance

MDCX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MDCX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.7%

Float: +84.8% of shares outstanding

Insider ownership

+8.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MDCX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.4

Neutral momentum band

Price vs 200-day MA

-79.1%

50/200-day relationship not available

Beta (5Y)

-0.91

Less volatile than the market

Sharpe ratio

-1.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MDCX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MDCX stock rating?

Medicus Pharma Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MDCX analysis?

The full report lives at /stocks/MDCX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MDCX?

The latest report frames MDCX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MDCX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.